Hologic, Inc. (HOLX) Tops Q4 EPS by 3c; Guides
Tweet
Share
E-mailGet Alerts HOLX Hot Sheet
Price: $76.01 --0%
Financial Fact:
Restructuring and divestiture charges: 2.9M
Today's EPS Names:
DTGI, CRMT, STZ, More
Financial Fact:
Restructuring and divestiture charges: 2.9M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Hologic, Inc. (NASDAQ: HOLX) reported Q4 EPS of $0.37, $0.03 better than the analyst estimate of $0.34. Revenue for the quarter came in at $588.5 million versus the consensus estimate of $558.7 million.
Hologic, Inc. sees Q1 2013 EPS of $0.37, which may not compare to the consensus of $0.36. Hologic, Inc. sees Q1 2013 revenue of $640-645 million.
Hologic, Inc. sees FY2013 EPS of $1.56-1.58, which may not compare the consensus of $1.51. Hologic, Inc. sees FY2013 revenue of $2.61-2.64 billion.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Hologic, Inc. sees Q1 2013 EPS of $0.37, which may not compare to the consensus of $0.36. Hologic, Inc. sees Q1 2013 revenue of $640-645 million.
Hologic, Inc. sees FY2013 EPS of $1.56-1.58, which may not compare the consensus of $1.51. Hologic, Inc. sees FY2013 revenue of $2.61-2.64 billion.
For earnings history and earnings-related data on Hologic, Inc. (HOLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Hologic recalls BioZorb markers after reported injuries - FDA
- Summit Hotel Properties refinances $650M credit facility through 2031
- Cronos Group replaces broker for Canadian share repurchase program
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
